Contents

Anti-Cancer Agents in Medicinal Chemistry, Volume 10 - Number 9

FK506 Binding Proteins as Targets in Anticancer Therapy

, 10(9): 651 - 656

Simona Romano, AnnaLaura Di Pace, Antonio Sorrentino, Rita Bisogni, Luigi Sivero and Maria Fiammetta Romano


DOI: 10.2174/187152010794479816




Cell Biological Manifestations of Bisdioxopiperazines: Treatment of Human Tumor Cell Lines in Culture

, 10(9): 657 - 660

Da-Yong Lu, Ding-Ren Lu and Jian Ding


DOI: 10.2174/187152010794479843




Targeted Therapies in Metastatic Melanoma: Toward a Clinical Breakthrough?

, 10(9): 661 - 665

Fanny Julia, Luc Thomas, Charles Dumontet and Stephane Dalle


DOI: 10.2174/187152010794479834




Potential New Agents for Chronic Lymphocytic Leukemia Treatment

, 10(9): 666 - 682

Malgorzata Rogalinska and Zofia M. Kilianska


DOI: 10.2174/187152010794479799




Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

, 10(9): 683 - 696

Joshua P. Sasine, Niramol Savaraj and Lynn G. Feun


DOI: 10.2174/187152010794479825




Discovery of Allosteric Inhibitors of Kinesin Spindle Protein (KSP) for the Treatment of Taxane-Refractory Cancer: MK-0731 and Analogs

, 10(9): 697 - 712

Christopher D. Cox and Robert M. Garbaccio


DOI: 10.2174/187152010794479807




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science